SCHEMBL19380990

SCHEMBL19380990

CC(NCCC(c1ccccc1)c1cc(N)nc(N)c1N)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.57
▸ OPRM1 P35372 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ HTR1A P08908 2/20 0.57
▸ ADORA3 P0DMS8 2/20 0.57
▸ SLC6A2 P23975 2/20 0.57
▸ SLC6A4 P31645 2/20 0.57
▸ ADRA1A P35348 2/20 0.57
▸ DRD3 P35462 2/20 0.57
▸ SLC6A3 Q01959 2/20 0.57
▸ KCNH2 Q12809 2/20 0.57
▸ CHRM2 P08172 1/20 0.57
▸ ADRA2A P08913 1/20 0.57
▸ CHRM1 P11229 1/20 0.57
▸ SMPD1 P17405 1/20 0.57
▸ DRD1 P21728 1/20 0.57
▸ TBXA2R P21731 1/20 0.57
▸ CASR P41180 1/20 0.57
▸ HTR2B P41595 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19381379 0.85 HTR2A (0.54) CYP3A4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL19381023 0.82 HRH1 (0.52) CYP3A4MPOHTR2AHRH1EPX
SCHEMBL19380918 0.80 MPO (0.67) CYP3A4KCNH2KMT2AMEN1MPO
SCHEMBL19359415 0.79 CYP3A4 (0.50) CYP3A4OPRM1LMNAHTR1AADORA3
SCHEMBL19380991 0.79 MPO (0.43) CYP3A4SLC6A4MPOHTR2AHRH1
SCHEMBL19359257 0.77 EPHX2 (0.60) CYP3A4LMNACYP2C19KMT2AMEN1
SCHEMBL19359262 0.77 PKM (0.45) CYP3A4LMNATBXA2RALDH1A1HTT
SCHEMBL19380989 0.77 PKM (0.45) CYP3A4LMNATBXA2RALDH1A1HTT
SCHEMBL19381378 0.77 EPHX2 (0.60) CYP3A4LMNACYP2C19KMT2AMEN1
SCHEMBL19381435 0.77 MPO (0.44) CYP3A4SLC6A4MPOEPXTPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161145-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-21 — — WO disclosed
Send feedback